Multiplicity in randomised trials I: endpoints and treatments. (Q53622606)
scientific article
Language:
Current Data About Multiplicity in randomised trials I: endpoints and treatments.
(P31) (Q13442814)
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018
(P854) http://europepmc.org/abstract/MED/15866314

(P50) (Q22959312)
(P1545) 2
(P1932) David A Grimes
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018

(Q114322619)
(P1545) 1
(P1932) Kenneth F Schulz
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018
(P854) http://europepmc.org/abstract/MED/15866314

(P304) 1591-1595
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018
(P854) http://europepmc.org/abstract/MED/15866314

(P407) (Q1860)

(P433) 9470
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018
(P854) http://europepmc.org/abstract/MED/15866314

(P478) 365
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018
(P854) http://europepmc.org/abstract/MED/15866314

(P577) Friday, April 1, 2005
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018
(P854) http://europepmc.org/abstract/MED/15866314

(P1433) (Q939416)
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018
(P854) http://europepmc.org/abstract/MED/15866314

(P1476) "Multiplicity in randomised trials I: endpoints and treatments." (language: en)
(P248)
(P698) 15866314
(P813) Wednesday, May 16, 2018
(P854) http://europepmc.org/abstract/MED/15866314

(P2860) (Q29615550)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q34417512)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q79098458)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q28292261)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q36683083)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q34103112)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q44618742)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q52902027)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q47385638)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q24524896)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q29618882)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q28185637)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q29618913)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q35132213)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q39361144)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q24569560)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q47372277)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

(Q79221427)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966461-6
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S0140-6736(05)66461-6
(P698) 15866314